{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:44:26Z","timestamp":1793133866054,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.kint.2025.05.039","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:56:55Z","timestamp":1755737815000},"page":"799-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Childhood-onset lupus nephritis: unique aspects and challenges in management"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-6005","authenticated-orcid":false,"given":"Eugene Yu-hin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.05.039_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0961203311412096","article-title":"Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus","volume":"20","author":"Pineles","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2215\/CJN.07810621","article-title":"Using a multi-institutional pediatric learning health system to identify systemic lupus erythematosus and lupus nephritis: development and validation of computable phenotypes","volume":"17","author":"Wenderfer","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib3","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","article-title":"Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort","volume":"64","author":"Watson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.24091","article-title":"Differences in long-term disease activity and treatment of adult patients with childhood-and adult-onset systemic lupus erythematosus","volume":"61","author":"Hersh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40272-023-00609-3","article-title":"Managing lupus nephritis in children and adolescents","volume":"26","author":"Chan","year":"2024","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.kint.2025.05.039_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/nep.14007","article-title":"Demographics and long-term outcomes of children with end-stage kidney disease: a 20-year territory-wide study","volume":"27","author":"Chan","year":"2022","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2025.05.039_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","article-title":"Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis","volume":"8","author":"Chan","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.05.039_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpeds.2007.09.019","article-title":"Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study","volume":"152","author":"Hiraki","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.kint.2025.05.039_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00467-006-0052-3","article-title":"Lupus nephritis in Chinese children\u2014a territory-wide cohort study in Hong Kong","volume":"21","author":"Wong","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib10","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/ndt\/gfp173","article-title":"Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre","volume":"24","author":"Vachvanichsanong","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0961203308097570","article-title":"Outcome of lupus nephritis in Indian children","volume":"18","author":"Hari","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/0886022X.2011.573897","article-title":"Lupus nephritis in Iranian children: a review of 60 patients","volume":"33","author":"Taheri","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2025.05.039_bib13","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2215\/CJN.00910111","article-title":"Three decades of progress in treating childhood-onset lupus nephritis","volume":"6","author":"Pereira","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/ndt\/gfs589","article-title":"Lupus nephritis in children and adolescents: results of the Italian Collaborative Study","volume":"28","author":"Ruggiero","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0961203315619031","article-title":"Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years","volume":"25","author":"Srivastava","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","article-title":"Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus","volume":"71","author":"Groot","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ndt\/gfab152","article-title":"Long-term renal survival of paediatric patients with lupus nephritis","volume":"37","author":"Demir","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib18","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-022-05811-y","article-title":"Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus","volume":"38","author":"Sakamoto","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib19","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1177\/09612033231202843","article-title":"Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India","volume":"32","author":"Biswas","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.23876\/j.krcp.23.032","article-title":"Long-term outcomes and associated prognostic risk factors of childhood-onset lupus nephritis","volume":"44","author":"Park","year":"2025","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.kint.2025.05.039_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00467-021-05164-y","article-title":"Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis","volume":"37","author":"Qiu","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0961203319826690","article-title":"Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort","volume":"28","author":"Ichinose","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib24","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/0961203312445230","article-title":"Predictors of survival in Chinese patients with lupus nephritis","volume":"21","author":"Zheng","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971\u20132015: a systematic review and Bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/ndt\/gfr663","article-title":"Renal-limited \u2018lupus-like\u2019 nephritis","volume":"27","author":"Huerta","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s004670050681","article-title":"Delayed onset of systemic lupus erythematosus in patients with\u201d full-house\u201d nephropathy","volume":"13","author":"Gianviti","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib30","first-page":"1194","article-title":"Outcome of childhood-onset full-house nephropathy","volume":"32","author":"Ruggiero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ndt\/gfx020","article-title":"Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome","volume":"32","author":"Rijnink","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.kint.2017.07.017","article-title":"Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits","volume":"93","author":"Rijnink","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/pr.2016.247","article-title":"Advances in the care of children with lupus nephritis","volume":"81","author":"Wenderfer","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.kint.2025.05.039_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-024-06498-z","article-title":"Renal vascular lesions in childhood-onset lupus nephritis","volume":"40","author":"Lin","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/archdischild-2020-321211","article-title":"Use of rituximab in paediatric nephrology","volume":"106","author":"Sinha","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.kint.2025.05.039_bib37","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib38","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/rheumatology\/keab746","article-title":"Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis","volume":"61","author":"De Mutiis","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2025.05.039_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110214","article-title":"Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force","volume":"263","author":"Smith","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2025.05.039_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00467-020-04686-1","article-title":"Kidney outcomes for children with lupus nephritis","volume":"36","author":"Oni","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0961203315615220","article-title":"Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis","volume":"25","author":"Aragon","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib42","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00467-024-06405-6","article-title":"Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis","volume":"39","author":"De Mutiis","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.semarthrit.2018.10.013","article-title":"How can we define low disease activity in systemic lupus erythematosus?","volume":"48","author":"Tselios","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-022-05742-8","article-title":"Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis","volume":"38","author":"Kisaoglu","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000571","article-title":"LLDAS is an attainable treat-to-target goal in childhood-onset SLE","volume":"8","author":"Wahadat","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2025.05.039_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109296","article-title":"PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)","volume":"250","author":"Smith","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2025.05.039_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110172","article-title":"First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort","volume":"262","author":"Bergkamp","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2025.05.039_bib48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Int Med"},{"key":"10.1016\/j.kint.2025.05.039_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#","article-title":"Estrogen enhancement of anti\u2013double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"42","author":"Kanda","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib50","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0961203317690616","article-title":"Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups","volume":"26","author":"Lopes","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12969-021-00528-y","article-title":"A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases","volume":"19","author":"de Gruijter","year":"2021","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib52","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3899\/jrheum.200002","article-title":"Relationship between genetic risk and age of diagnosis in systemic lupus erythematosus","volume":"48","author":"Dominguez","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib53","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.kint.2025.05.039_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/kead447","article-title":"Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study","volume":"63","author":"Chan","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2025.05.039_bib55","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","article-title":"European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/pediatric14020030","article-title":"Lupus nephritis, autoantibody production and kidney outcomes in males with childhood-onset systemic lupus erythematosus","volume":"14","author":"Wenderfer","year":"2022","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.kint.2025.05.039_bib57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3899\/jrheum.170226","article-title":"Longterm data on disease flares in patients with proliferative lupus nephritis in recent years","volume":"44","author":"Yap","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib58","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical\u2013histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheumat Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12969-015-0024-x","article-title":"Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatr Nephrol Consortium and the Childhood Arthritis and Rheumatology Research Alliance","volume":"13","author":"Wenderfer","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2025.05.039_bib60","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1093\/rheumatology\/keaa129","article-title":"Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis","volume":"59","author":"Parodis","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2025.05.039_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00005-022-00646-9","article-title":"Treat-to-target in lupus nephritis. What is the role of the repeat kidney biopsy?","volume":"70","author":"Parodis","year":"2022","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.kint.2025.05.039_bib62","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/acr.25002","article-title":"Childhood-onset lupus nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: short-term kidney status and variation in care","volume":"75","author":"Smitherman","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12969-018-0271-8","article-title":"Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study","volume":"16","author":"Sit","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2025.05.039_bib64","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00467-020-04501-x","article-title":"Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study","volume":"35","author":"Suhlrie","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/acr.24461","article-title":"Timing of childhood-onset systemic lupus erythematosus diagnosis relative to menarche and the impact on final adult height","volume":"74","author":"Sontichai","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib66","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00431-020-03910-2","article-title":"Longitudinal growth patterns and final height in childhood-onset systemic lupus erythematosus","volume":"180","author":"Jongvilaikasem","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.kint.2025.05.039_bib67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12969-022-00663-0","article-title":"Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus","volume":"20","author":"Ponin","year":"2022","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152068","article-title":"The pediatric Glucocorticoid Toxicity Index","volume":"56","author":"Brogan","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152516","article-title":"Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus","volume":"68","author":"Zhang","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.41930","article-title":"International consensus for the dosing of corticosteroids in childhood-onset systemic lupus erythematosus with proliferative lupus nephritis","volume":"74","author":"Chalhoub","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00467-023-05974-2","article-title":"Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review","volume":"39","author":"Lai","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib72","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ndt\/gfy284","article-title":"Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis","volume":"35","author":"Yap","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib73","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00467-016-3507-1","article-title":"Ten-year treatment with mycophenolate mofetil using therapeutic drug monitoring for childhood-onset lupus nephritis in Japan","volume":"32","author":"Fujinaga","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-020-04733-x","article-title":"Mycophenolic acid area under the curve is associated with therapeutic response in pediatric lupus nephritis","volume":"36","author":"Godron","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib76","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00467-024-06367-9","article-title":"Do we really need cyclophosphamide for lupus nephritis?","volume":"39","author":"Wenderfer","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib77","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3899\/jrheum.210428","article-title":"Use of EuroLupus cyclophosphamide dosing for the treatment of lupus nephritis in childhood-onset systemic lupus erythematosus in North America","volume":"49","author":"Cannon","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/art.42725","article-title":"Renal response outcomes of the EuroLupus and NIH cyclophosphamide dosing regimens in childhood-onset proliferative lupus nephritis","volume":"76","author":"Wang","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib79","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1470-2045(14)70408-5","article-title":"Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study","volume":"15","author":"Green","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.kint.2025.05.039_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2022.05.013","article-title":"Clinical factors and adverse kidney outcomes in children with antineutrophil cytoplasmic antibody\u2013associated glomerulonephritis","volume":"81","author":"Marlais","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib81","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.kint.2024.09.011","article-title":"An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome","volume":"106","author":"Chan","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib82","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib83","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids","volume":"72","author":"Condon","year":"2013","journal-title":"Ann Rheumat Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203314547793","article-title":"The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE","volume":"24","author":"Watson","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2025.05.039_bib85","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.21351","article-title":"B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus","volume":"52","author":"Marks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2025.05.039_bib86","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1007\/s00467-023-06025-6","article-title":"Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis","volume":"38","author":"Chan","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib87","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rdc.2017.04.005","article-title":"Genomics of systemic lupus erythematosus: insights gained by studying monogenic young-onset systemic lupus erythematosus","volume":"43","author":"Hiraki","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.kint.2025.05.039_bib88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/BOR.0000000000001008","article-title":"Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities","volume":"36","author":"Qin","year":"2024","journal-title":"Current Opin Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40348-024-00181-x","article-title":"Monogenic lupus\u2014from gene to targeted therapy","volume":"11","author":"Menzel","year":"2024","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.kint.2025.05.039_bib90","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2025.05.039_bib91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.kint.2020.10.037","article-title":"Improving medication adherence in patients with lupus nephritis","volume":"99","author":"Costedoat-Chalumeau","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib92","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/acr.22749","article-title":"Lupus means sacrifices: perspectives of adolescents and young adults with systemic lupus erythematosus","volume":"68","author":"Tunnicliffe","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib93","first-page":"1604","article-title":"Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?","volume":"33","author":"Cunha","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.05.039_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","article-title":"Adherence to treatment in systemic lupus erythematosus patients","volume":"27","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib95","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/acr.22636","article-title":"Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus","volume":"67","author":"Feldman","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ibd\/izaa056","article-title":"Utility of the MARS-5 in assessing medication adherence in IBD","volume":"27","author":"Stone","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib97","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/kex337","article-title":"Treatment adherence in systemic lupus erythematosus and rheumatoid arthritis: time to focus on this important issue","volume":"57","author":"Costedoat-Chalumeau","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2025.05.039_bib98","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.24806","article-title":"Pilot intervention to improve medication adherence among patients with systemic lupus erythematosus using pharmacy refill data","volume":"75","author":"Sun","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib99","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cpt.1194","article-title":"A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and self-administered questionnaires","volume":"106","author":"Costedoat-Chalumeau","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.kint.2025.05.039_bib100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2215\/CJN.10370818","article-title":"Patients\u2019 and nephrologists\u2019 evaluation of patient-facing smartphone apps for CKD","volume":"14","author":"Singh","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12969-020-00430-z","article-title":"Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic lupus erythematosus","volume":"18","author":"Harry","year":"2020","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib102","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-018-0232-2","article-title":"Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study","volume":"16","author":"Scalzi","year":"2018","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib103","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3899\/jrheum.110771","article-title":"Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus","volume":"39","author":"Ting","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2025.05.039_bib104","series-title":"Pediatric Kidney Disease","first-page":"737","article-title":"Lupus nephritis","author":"Marks","year":"2023"},{"key":"10.1016\/j.kint.2025.05.039_bib105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/acr.22611","article-title":"Transition of care and health-related outcomes in pediatric-onset systemic lupus erythematosus","volume":"67","author":"Felsenstein","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.kint.2025.05.039_bib106","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/annrheumdis-2016-210112","article-title":"EULAR\/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases","volume":"76","author":"Foster","year":"2017","journal-title":"Ann Rheumat Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib107","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00467-024-06654-5","article-title":"The unique challenges of childhood-onset systemic lupus erythematosus and lupus nephritis patients: a proposed framework for an individualized transitional care plan","volume":"40","author":"Renson","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib108","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12969-021-00651-w","article-title":"A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes","volume":"19","author":"Overbury","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2025.05.039_bib109","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1016\/j.kint.2025.05.039_bib110","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.05.039_bib111","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheumat Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib112","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/17512433.2022.2138340","article-title":"Novel and emerging treatment strategies for lupus nephritis","volume":"15","author":"Yap","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.kint.2025.05.039_bib113","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.kint.2021.08.027","article-title":"A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis","volume":"101","author":"Rovin","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.05.039_bib114","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann Rheumat Dis"},{"key":"10.1016\/j.kint.2025.05.039_bib115","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1007\/s00431-024-05662-9","article-title":"Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis","volume":"183","author":"Li","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.kint.2025.05.039_bib116","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-021-05345-9","article-title":"Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome","volume":"37","author":"Chan","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2025.05.039_bib117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","article-title":"A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825006453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825006453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:20:02Z","timestamp":1760826002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825006453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0085253825006453"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.05.039","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood-onset lupus nephritis: unique aspects and challenges in management","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}